CytoSorbents Corp (CTSO)
0.80
-0.05
(-5.88%)
USD |
NASDAQ |
May 02, 16:00
0.80
0.00 (0.00%)
After-Hours: 17:38
CytoSorbents Free Cash Flow: -22.59M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -22.59M |
September 30, 2023 | -21.59M |
June 30, 2023 | -23.58M |
March 31, 2023 | -29.51M |
December 31, 2022 | -34.69M |
September 30, 2022 | -36.31M |
June 30, 2022 | -34.01M |
March 31, 2022 | -24.30M |
December 31, 2021 | -18.29M |
September 30, 2021 | -12.45M |
June 30, 2021 | -10.98M |
March 31, 2021 | -6.522M |
December 31, 2020 | -7.290M |
September 30, 2020 | -10.49M |
June 30, 2020 | -12.33M |
March 31, 2020 | -17.28M |
December 31, 2019 | -18.28M |
September 30, 2019 | -16.78M |
June 30, 2019 | -14.17M |
March 31, 2019 | -14.40M |
December 31, 2018 | -12.36M |
September 30, 2018 | -10.32M |
June 30, 2018 | -10.13M |
March 31, 2018 | -8.626M |
December 31, 2017 | -8.139M |
Date | Value |
---|---|
September 30, 2017 | -8.325M |
June 30, 2017 | -8.257M |
March 31, 2017 | -8.147M |
December 31, 2016 | -7.326M |
September 30, 2016 | -8.594M |
June 30, 2016 | -8.388M |
March 31, 2016 | -8.958M |
December 31, 2015 | -9.691M |
September 30, 2015 | -9.527M |
June 30, 2015 | -9.068M |
March 31, 2015 | -7.923M |
December 31, 2014 | -6.648M |
September 30, 2014 | -5.635M |
June 30, 2014 | -4.214M |
March 31, 2014 | -3.72M |
December 31, 2013 | -3.706M |
September 30, 2013 | -3.219M |
June 30, 2013 | -3.279M |
March 31, 2013 | -3.383M |
December 31, 2012 | -3.655M |
September 30, 2012 | -3.985M |
June 30, 2012 | -4.477M |
March 31, 2012 | -4.377M |
December 31, 2011 | -3.881M |
September 30, 2011 | -3.582M |
Free Cash Flow Range, Past 5 Years
-36.31M
Minimum
Sep 2022
-6.522M
Maximum
Mar 2021
-19.55M
Average
-18.28M
Median
Dec 2019
Free Cash Flow Benchmarks
Delcath Systems Inc | -31.31M |
Star Equity Holdings Inc | 2.00M |
Exact Sciences Corp | 31.93M |
Illumina Inc | 282.00M |
Progyny Inc | 185.17M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -6.407M |
Cash from Investing (Quarterly) | -0.1359M |
Cash from Financing (Quarterly) | 12.21M |
Free Cash Flow Per Share (Quarterly) | -0.1406 |
Free Cash Flow to Equity (Quarterly) | -6.554M |
Free Cash Flow to Firm (Quarterly) | -6.498M |
Free Cash Flow Yield | -63.24% |